AstraZeneca to invest $2.5 bn in new R&D centre, biotech agreements and manufacturing in… EP News Bureau Mar 24, 2025 In addition, AstraZeneca is launching a new joint venture with BioKangtai, to develop, manufacture, and commercialise innovative…
AstraZeneca signs manufacturing pact with Chinese firm, BioKangtai for COVID-19 vaccine EP News Bureau Aug 7, 2020 As per the deal, AstraZeneca will deliver the first 100 million doses this year and 200 million doses by the end of 2021
